ABSTRACT Over 40% of mammalian genomes comprise the products of reverse transcription. Among such retrotransposed sequences are those characterized by the presence of long terminal repeats (LTRs), including the endogenous retroviruses (ERVs), which are inherited genetic elements closely resembling the proviruses formed following exogenous retrovirus infection. Sequences derived from ERVs make up at least 8 to 10% of the human and mouse genomes and range from ancient sequences that predate mammalian divergence to elements that are currently still active. In this chapter we describe the discovery, classification and origins of ERVs in mammals and consider cellular mechanisms that have evolved to control their expression. We also discuss the negative effects of ERVs as agents of genetic disease and cancer and review examples of ERV protein domestication to serve host functions, as in placental development. Finally, we address growing evidence that the gene regulatory potential of ERV LTRs has been exploited multiple times during evolution to regulate genes and gene networks. Thus, although recently endogenized retroviral elements are often pathogenic, those that survive the forces of negative selection become neutral components of the host genome or can be harnessed to serve beneficial roles.
INTRODUCTION
Mammalian genomes have accumulated millions of retrotransposed sequences during evolution. This material can be divided into long terminal repeat (LTR) retrotransposons that include the endogenous retroviruses (ERVs), as well as long and short retrotransposons lacking LTRs, known as LINEs and SINEs, respectively. ERVs are defined as inherited genetic elements closely resembling the proviruses formed following exogenous retrovirus infection. In this chapter we describe the discovery, classification, and origins of ERVs in mammals, consider cellular mechanisms that have evolved to control their expression, and discuss the biological consequences, both positive and negative from the host's standpoint, of ERV inheritance.
DISCOVERY OF ERVs
In the mid-1960s, prompted in large part by the economic impact of a leukosis-causing retrovirus in chicken flocks, serological assays for antibodies to viral Gag proteins were developed to identify birds exposed to avian leukosis virus (ALV) infection. Strangely, a number of birds scored positive in the absence of overt infection and apparent exposure followed Mendelian inheritance. Simultaneously, further virological studies revealed the expression of functional Env proteins in certain birds; expression of viral Gag and Env cosegregated in genetic crosses. Together these findings suggested that the viral proteins were encoded in the chicken genome (1) . In retrospect, with our current knowledge of the retroviral life cycle, this suggestion would be regarded as uncontroversial. However, at that time retroviruses were still thought of purely as RNA viruses and the suggestions of proviruses in DNA form, despite the knowledge that phage could lysogenize, were met with considerable skepticism. It was only with the discovery of an enzyme capable of converting RNA into DNA, reverse transcriptase, that the idea of an ERV, inherited in the germ line as DNA, became palatable (Fig. 1A) .
At about the same time, similar experiments were being conducted in the murine system, with evidence accumulating that retroviruses could be induced by radiation or chemicals from apparently virus-free cells (2) and that retrovirus-related sequences could be detected by liquid hybridization in genomic DNA (3) . Two classes of murine ERVs were detected in this way, mouse mammary tumor virus (MMTV) and murine leukemia virus (MLV). As their names suggest, ALV, MMTV, and MLV can cause cancer or, if they do not, are related to cancercausing viruses. This raised the question, still unresolved (see "Pathogenic effects of ERVs and related sequences on the host" below), of ERV involvement in human cancer, and prompted an ongoing series of searches for ERVs in other species, particularly in humans.
Two different approaches have been utilized in these experiments (4) . The first, which might be labeled biological, is based on the functional properties of an active retrovirus and involves the search for a replicating virus. The second, which might be considered structural, looks for nucleic acid sequences related to known retroviruses or having the sequence organization of a retrovirus. An example of the first approach involves treatment of cells with inducing agents, agents that have already been shown to activate ERVs in other species (such as the demethylating agent 5-azacytidine), and coculture of these cells or the cell-free supernatant with an appropriate indicator cell to monitor for the appearance of viral markers such as reverse transcriptase activity (5) . In this way, infectious ERVs have been recovered from multiple species but not from humans. Alternately, cells from a tumor might be introduced into animals unable to mount an immune response and the virus production monitored. This approach has mainly been employed to try to find agents involved in tumor causation; ironically, viruses isolated in this fashion tend to represent ERVs from the transplanted animal rather than from the tumor itself (6) . A number of false associations between retroviruses and cancer have been reported as a result of such studies; these are frequently referred to as "rumor viruses" (7) .
Structural approaches are exemplified by early experiments to clone human ERVs using low-stringency hybridization with cloned ERV probes obtained from other species (8, 9) . In this way sequences related to the murine viruses MLV and MMTV were cloned and characterized. Later, ERVs from chickens lacking endogenous ALVs were cloned in a similar fashion (10) . Subsequently, PCRbased approaches using primers complementary to conserved regions of pol became more widely used (11, 12, 13) . These experiments began to reveal the number and diversity of ERVs present in the DNA of different species.
Ultimately, it was the analysis of sequence data (14, 15) , particularly when whole genome sequences became available (16, 17, 18, 19) , that revealed the full contribution of ERVs to the compositions of vertebrate genomes. Indeed, the initial analyses of the human genome sequence showed that a larger percentage of our DNA comprises ERV-related material (8%) than encodes proteins (1 to 2%). Since the completion of the first human sequence, DNA-sequencing technology has improved dramatically with a corresponding decrease in costs. This has led to the completion of multiple genome-sequencing projects. Simultaneously, a variety of in silico techniques for identifying and annotating potential ERVs have been developed (20) . These entail searches for conserved sequences and/or sequence motifs organized in the same manner as exogenous retroviruses (21) . Using such mining techniques, comprehensive ERV collections have been obtained from ever-increasing numbers of species (22, 23) . Thus, one recent paper refers to 87,750 defined ERVs identified in an analysis of 60 vertebrate genomes (24) , and these numbers can only increase with time. Studies of their relationship to one another and their biological impact therefore present significant challenges.
STRUCTURE AND CLASSIFICATION
Examination of the genetic structures of different LTRretrotransposons identified in genomic DNA reveals four fundamental forms (Fig. 1B) . First are structures essentially indistinguishable from the integrated proviruses of exogenous retroviruses and will be referred to as "complete" ERVs. They contain two LTRs ranging in size from 300 to 1000 bp with signals to regulate transcription separated by around 6 to 9kb encoding the viral Gag, Pol, and Env proteins. Signals for RNA polyadenylation, splicing, and packaging in virions are also present, as well as the tRNA primer-binding site (PBS) and polypurine tract that define boundaries of the LTRs. The ERV sequences are flanked by a short (4 to 6 bp) duplication of host sequences. The endogenous MLVs of mice (25) are well-characterized members of this form of ERVs. With a relatively few exceptions, notably HERV-K (HML-2) in primate genomes (26) , genes encoding viral accessory proteins are not present in ERVs (27) .
A second group, which might be thought of as "slimmed down" retroviruses that lack one or more coding sequence FIGURE 1 (A) Formation of ERVs. Exogenous retroviruses typically infect their host and spread to other individuals via horizontal transmission. When retroviruses infect and integrate into the genome of germ line cells, the provirus can be vertically transmitted and become endogenous to the host. ERVs can amplify in the host genome through reinfection or through intracellular retrotransposition (see text). (B) Basic structures of ERVs. Complete ERVs are essentially identical to the integrated proviruses of simple exogenous retroviruses; they contain two LTRs made up of unique 3′ (U3), repeat (R), and unique 5′ (U5) regions, a primer binding site (pbs) and polypurine tract (ppt), as well as a full complement of coding sequences (gag, pol, and env), splice donor (SD) and acceptor (SA) sites, and an RNA packaging signal (psi). "Slimmed down" ERVs are elements lacking coding sequences compared to a complete ERV-here illustrated with a deletion in env. "Substituted" ERVs are elements in which the ERV coding sequences have been replaced with nonviral sequences. "Solo LTRs" are single LTRs generated by homologous recombination between the two LTRs of a complete element. doi:10.1128/microbiolspec.MDNA3-0009-2014.f1
(usually the env gene) essential for autonomous extracellular replication, but not ruling out an intracellular replication cycle resembling the Ty elements of yeast. In contrast to the retrotransposable elements of yeast, it seems likely that these elements derive from complete proviruses by the loss of specific genes and they may carry an altered assembly/budding signal in gag. Examples include the intracisternal A type particle (IAP) (28) and MusD (29) ERVs of mice.
A third group contains elements with two LTRs and an appropriately positioned PBS and polypurine tract, but no other recognizable homology with retroviral proteins. Perhaps such elements arose by mechanisms of read-through transcription and illegitimate recombination similar to those thought to be associated with oncogene transduction by retroviruses (30) . Provided they contain appropriate RNA packaging sequences, such elements might be replicated in a manner similar to the genomes of retroviral vectors. Examples include the early transposons (ETns) of mice (31) , which are retrotransposed by the related MusD ERVs (29) , and THE1 mammalian apparent LTR-retrotransposon (MaLR) elements in humans (14) . Overall, these nonautonomous elements have received relatively little attention, although ETn elements are still retrotransposing in mice (32) .
The final group of sequences, present in an approximately 10-fold excess in the genome over the other groups, are the so-called "solo LTRs." Although they contain a number of short motifs essential for integration into chromosomal DNA and the control of RNA transcription, they are difficult to identify from scratch (33) and are usually found by their sequence similarity to the LTRs of complete viruses described above. These are thought to arise by homologous recombination between the LTRs of complete elements (34) . In one case, an MLV associated with the dilute coat-color mutation of mice, in which recombination between the LTRs causes a readily identifiable phenotypic effect, the rate of proviral loss has been estimated at 4.5 × 10 −6 excisions per meiosis (35) .
Despite the abundance of ERV elements revealed by genome sequencing only a few replicating ERVs have been isolated by induction/culture techniques. Examination of the predicted ERV coding sequences provides a ready explanation for this observation. Very few elements have complete open reading frames for Gag, Pol, and Env (36, 37) . Most elements contain numerous mutations, consistent with neutral evolution for significant periods of time and lengthy periods of residence in the germ line, although some proviruses reveal evidence for inactivating mutations that occurred prior to integration (38) . In the human genome, even the most recent ERV insertions, those of the HERV-K (HML-2) group, require multiple changes to allow the rescue of infectious viruses (39, 40) .
Classifying and naming ERVs, particularly down to the level of individual proviral loci, remains a considerable problem (41, 42) , so far without final resolution. ERV sequences with internal homology to retroviruses can be placed into one of three classes based on phylogenetic analyses of the conserved regions of the pol gene. Class I elements are most closely related to the exogenous gamma-and epsilonretroviruses, Class II to the alpha-and betaretroviruses, and Class III to the spumaviruses (see Table 1 for ERV representatives of each class). The large category of MaLR LTR elements, although they lack a detectable pol-related sequence, is sometimes also considered "Class III" due to the slight homology of some members to Class III gag sequences. These classes can be further subdivided into groups (not families, a term reserved for higher order taxa of viruses) each apparently derived from individual germ line infections (43) . However, a number of discrepancies arise when ERVs are analyzed on the basis of their env genes, a finding that illustrates the confounding effects of recombination on phylogenetic analysis (44) .
The nomenclature system for ERVs has developed in a manner reflecting the history of their discovery. It first became common to name endogenous proviruses after the most closely related exogenous retrovirus, such as MLV, as well as subgroups, like xenotropic MLV. It is now standard to add one or two letters before the designation ERV to indicate the species in which they were initially identified; thus, HERV indicates an ERV first seen in human DNA and MERV or MuERV implies one originally found in mice. HERVs are further classified on the basis of the tRNA that binds to the viral PBS to prime reverse transcription. Hence, HERV-K implies a provirus or groups of proviruses that utilize a lysine tRNA, no matter their relationship to one another. In some cases the PBS sequence was not available when novel elements were first discovered, leading to the names based on neighboring genes or the probe used for cloning. A further problem is to distinguish different members of a phylogenetic group that differ by integration site rather than coding sequence and possibly are present in hundreds of copies. Nomenclature became even more complicated with the realization that the majority of ERVs entered the germ line before modern species were established (see below). If a provirus integrated at a given position in the genome is present in both chimpanzee and human, should it be called a CERV or a HERV? Further, how do you indicate that these orthologous proviruses in different species are more closely related to one another than to other proviruses of the same viral group within one species? Another complicated aspect of ERV nomenclature is that Repbase, the widely used and valuable database of genomic repeats (45) , by necessity designates groups of ERVs and solitary LTRs with numerical names that can be confusing. For example, mouse LTRs related to MLV are designated RLTR4 in Repbase and LTRs related to the primate HERV9 group are designated as LTR12. Helpful tables listing various naming schemes for human ERVs and associated LTRs have been published (46, 47) . However, considerable confusion remains; the development of a rational scheme of classification and nomenclature for all ERVs would be of great value.
Studies of the distribution of different ERVs in the genomes of multiple species, using in silico methods such as RepeatMasker and RetroTektor, are now providing a series of valuable insights into the evolution of retrovirus-host interactions. Class I, II, and III ERVs, along with the ancient MaLR elements, are present in all mammalian species tested, but their relative proportions and abundance differ from species to species (48, 49) , reflecting different evolutionary dynamics within the host (Fig. 2) . One notable example of different ERV distributions among mammals is the significant expansion of Class II ERVs in the mouse. The number of different groups of sequences belonging to each Class ranges from one to 20 (43) and each group can vary in size from one to in excess of a thousand. It is possible to examine their integration sites relative to other features of the genome to investigate the genetic impact of inherited elements (see below). One can define novel elements and seek to define the origins of ERVs (49) . Transmissions between species and, more rarely, between different evolutionary orders can be demonstrated (24) and hypotheses regarding their possible pathogenic potential developed (50) . One interesting set of data reveals that ERVs lacking an env gene have been particularly successful in amplifying their copy number (23), thus constituting genomic superspreaders.
ACQUISITION AND AMPLIFICATION
Two methods have been used to estimate the age of specific ERV elements, both based on the properties of retroviral replication, thought to be the mechanism underlying ERV acquisition and amplification (see below). The first relies on the observation that the choice of retroviral integration site is essentially random. It follows that proviruses mapped at exactly the same position in two different species are likely to be descendants from the same integration event. The presence of such orthologous ERVs, which can readily be detected by PCR using primers directed to conserved flanking sequences, implies integration before divergence and provides a minimum estimate for the time of integration. This method, although it requires integration site data from multiple species, has found wide use in dating primate proviruses (51, 52) . The second method takes advantage of the fact that the process of reverse transcription generates two LTRs with identical sequences and thus no differences are present in the LTRs of a newly integrated provirus. Differences will subsequently accumulate at a rate proportional to the host organism's neutral mutation rate. Thus, the number of differences between the two LTRs ASMscience.org/MicrobiolSpectrumof a given provirus will provide an estimate of the time that element was integrated (43) . This method can be applied to single genomic sequences but can be compromised by reverse transcriptase errors and, particularly for older ERVs, by the insertion of other elements, by back mutation, and by gene conversion (53) . Using these methods a number of conclusions may be drawn about the history of ERV and their hosts. These include: (i) the formation of novel ERVs has been occurring continuously during the course of mammalian evolution (54); (ii) in their modern form retroviruses essentially have existed for tens, if not hundreds, of millions of years (27, 55) ; (iii) amplification of a given ERV group can continue gradually for tens of millions of years, sometimes interspersed with bursts of amplification, either through intercell infections or retrotransposition, but it seems to come to a stop eventually (52, 56) ; (iv) in some species, including humans, germ line colonization by novel ERVs has virtually ceased, whereas in others, like mice, it continues apparently unabated (57, 58) . It is unclear why mammalian species differ in their level of present-day ERV activity but such differences could result from population bottlenecks, host restriction genes, and/or random chance.
Most original endogenizations took place in the distant past, but a series of experiments, mainly carried out in mice in the 1970s and 1980s, allows us to deduce the likely events leading to the current repertoire of ERV elements. First came experiments showing that the in vitro infection of preimplantation embryos with Moloney MLV followed by reimplantation leads to the development of novel Moloney MLV-derived ERVs in up to half the exposed embryos (59) . Analogous experiments were later performed with murine embryonic stem (ES) cells and fertilized chicken eggs. Next came experiments to examine the spontaneous germ line amplification of MLV proviruses that had been observed to occur in strains of mice naturally expressing high levels of endogenous MLV in somatic tissues. It rapidly became apparent that germ line amplification only occurred in the progeny of viremic females but not in viremic males, implying a requirement for cells or tissues of the female germ line in amplification (60) . This idea was tested directly in transplant experiments (61) . Ovaries from nonviremic females were implanted into the ovarian bursas of viremic animals. Novel ERVs were shown to be present in the progeny of the virus-negative transplanted oocytes, demonstrating infection after transplantation. Further transplantation experiments of virus-negative oocytes into females that were viremic as a result of infection rather than genomic inheritance also revealed the generation of novel ERVs. It therefore seems reasonable to conclude that virus infection, possibly from a different species, could result in viremia and the infection of oocytes. Following fertilization and the birth of progeny, the novel endogenous elements, provided that they do not prove harmful, could then be fixed by random breeding. Thus, a new group of ERVs could colonize a novel species. Once established, amplification could then occur by extracellular reinfection of oocytes recapitulating the original infection.
Different ERV groups are present in very different copy numbers, indicating that amplification can follow very different trajectories. The factors responsible for these different fates are unclear, but might involve the rapid mutational loss of genes required for amplification or the development of host mechanisms to suppress replication (54, 56) . Alternately, the ERV might undergo a more dramatic genetic change. The evolutionary success of the superspreaders, such as IAP elements in mice, suggests the development of an intracellular replication strategy resembling the retrovirus life cycle but lacking budding from and reentering the cell, might be advantageous (23) . Perhaps replication in this manner is intrinsically more efficient; alternately, it avoids host responses to infection (see below). A further evolution of ERVs might involve loss of the sequences encoding replicative functions, such as Gag and Pol. If these can be supplied in trans in a manner resembling the preparation of a retroviral vector, and are replaced by an RNA that is efficiently packaged and reversed transcribed, evolution of a nonautonomous element might take place.
Until recently, the opportunity for following the process of endogenization in a natural setting had not arisen. However, this situation has now changed with the observation of a spreading wave of germ line colonization in the koala by a virus called KoRV-A. This virus is present in variable copy number in genomic DNA of all koalas present in the north of Australia but appears absent in a fraction of the animals found in the south (62, 63) . High levels of expression are seen in newborn joeys, but it remains unclear whether this results from the endogenous virus or the concomitant exogenous virus spreading. KoRV expression is associated with lymphomas in captive koalas (64) . However, here the relative contributions of endogenous and exogenous virus are also unclear. Initial estimates suggested that KoRV first became endogenous around 100 years ago and was derived from an ERV present in rodent species found in Southeast Asia that also gave rise to a virus that caused disease in gibbon apes (63) . Although neither inference can be considered conclusive (65, 24) , the current epidemic offers a number of opportunities for studying the process of cross-species infection leading to endogenization. For example, it should present opportunities to identify the source of the virus in koalas, assess how it reached the geographically isolated target population, how copy number is controlled, and whether KoRV shows a tendency to become less pathogenic when establishing itself as a neo-ERV. Adding urgency to these experiments is the possibility that KoRV might contribute to the extinction of an iconic species.
HOST DEFENSES AGAINST ERVs
Given their potential for harm, genomes have evolved multiple lines of defense against ERVs involving both epigenetic modifications that curtail ERV transcription as well as host protein restriction factors that target other phases of the ERV replication cycle (54, 66, 67, 68, 69, 70) .
Epigenetic mechanisms Epigenetics of ERV suppression
In the mouse it has been shown that, depending on tissue type, ERV transcription is suppressed by DNA methylation and/or repressive histone modifications (for reviews, see references 68, 69, 71) . DNA methylation in mammals is generally associated with transcriptional silencing and nearly always involves the addition of a methyl group to the fifth carbon of cytosine at CpG sites, catalyzed by three DNA methyltransferases (Dnmts), the de novo Dnmt3a and Dnmt3b, and the maintenance Dnmt1 (72) . DNA methylation plays an important role in suppressing mouse ERV transcription in somatic cells (73, 74, 75) , as well as in the later stages of germ line development (76) . During epigenetic reprogramming in preimplantation mouse embryos, loss of DNA methylation occurs and numerous ERVs, including MERV-L and ETn/MusD elements, are derepressed and expressed at very high levels (32, 77, 78) . In Dnmt1-/-mouse embryos, both MLV and IAP ERVs become demethylated, and IAP transcripts are expressed up to 100-fold higher relative to wild-type embryos (75, 79) .
In humans, although ERV transcripts are detectable in many cell types (80) (81, 82, 83, 84, 85, 86) . The CpG substitution rate in primate genomes is significantly higher in repeats such as L1 retroelements and ERVs compared to nonrepetitive DNA, suggesting a homology-dependent methylation mechanism (87) . Indeed, a specialized small RNA (piRNA) pathway promotes DNA methylation of mouse ERVs in the developing the male germ line (88) . There is evidence that small RNA pathways promote DNA methylation and suppression of the activity of human LINE1 non-LTR retroelements (89), but their role in human ERV suppression is unclear.
Although DNA methylation is important for the silencing of ERVs in somatic tissues, histone modifications also play major roles, particularly in undifferentiated and/or stem cells. H3K9me2 or H3K9me3, both associated with transcriptional repression (90), have major roles in mouse ERV suppression. In mouse ES cells, H3K9me3 is associated with Class I and II ERVs (but not Class III ERVs) (91) and is required for the silencing of these ERVs, including IAP elements (92, 93) . Many ERV groups are derepressed in H3K9me3-deficient but not Dnmt triple knockout (Dnmt1-/-, Dnmt3a-/-, Dnmt3b-/-) ES cells. This derepression leads to upregulation of several genes as a result of ERV LTRs acting as alternative promoters (94) . H3K9me3 is deposited on mouse Class I and II ERVs by the SETDB1/ KAP1 complex (92, 93) . As KAP1 interacts with Krüppel-associated box zinc finger proteins (KRAB-ZFPs), of which there are several hundred in mammals (95) , it has been proposed that the SETDB1/KAP1 complex is recruited to distinct ERVs by a variety of different KRABZFPs (69, 71, 96) . Indeed, a particular KRAB-ZFP (ZNF809) is required for the silencing of MLV in ES cells through binding to the MLV primer binding site (PBS) (96) . Moreover, genomic comparative studies suggest that the rapid evolution and expansion of KRAB-ZFPs in mammalian genomes has been an "arms-race" response to invasions of retroviruses in the past (95) .
H3K9me3 is not the only repressive mark associated with ERV silencing. H3K9me2 is required for the silencing of a distinct set of ERVs, predominantly Class III MERV-L elements, in mouse ES cells, and, when this mark is depleted, some genes are upregulated via upstream MERV-L LTRs (97) . Aberrant expression of MERV-L-driven chimeric gene transcripts also occurs in ES cells deficient for the H3K4 demethylase Lsd1 (98) . Upregulation of MLV and IAP ERVs, associated with loss of the repressive mark H3K27me3, was also observed in mouse ES cells deficient for H3K27 methyltransferases (99). Thus, both DNA methylation and various repressive histone modifications are involved in ERV transcriptional silencing.
Epigenetics of active ERVs
Although most studies have focused on the epigenetic suppression of ERVs, those elements that do show promoter or enhancer activity appear to be associated with active epigenetic marks, as would be expected (100). For example, tissue-specific hypomethylated LTRs and other retroelements gain H3K4me1 (an enhancer mark) and exhibit enhancer activity in reporter assays (86) . Mouse ES cells depleted of Kap1 lose the repressive mark H3K9me3 at IAP ERVs and gain enhancer marks H3K27ac and H3K4me1, which correlates with their upregulation and the induction of a subset of nearby genes (101) . Mouse LTRs close to actively transcribing genes can acquire the active promoter mark H3K4me3, are unmethylated, and can act as alternative promoters for the neighboring gene (102) . In mice harboring a large portion of human chromosome 21, many normally silent LTRs on this chromosome are transcribed and are associated with a lower DNA methylation and active epigenetic marks (103), suggesting that the lack of speciesspecific repressive mechanisms can lead to widespread transcriptional activation of ERV sequences.
Restriction factors
A number of cellular proteins interfering with retrovirus replication have been described. Several were first identified as factors blocking HIV-1, but more detailed studies revealed activity against multiple kinds of virus including ERVs (54, 104, 105) . Foremost on this list are members of the APOBEC3 family of cytidine deaminases. APOBEC3G was first shown to inhibit HIV-1 replication (106) with plausible mechanisms, including lethal mutation of viral genomes by cytosine deamination and interference with reverse transcription (107) . There are 11 members of this protein family, several with antiretrovirus or antiretrotransposon activity. TRIM5α (108) belongs to an even larger family of cellular proteins, many of which have roles in the innate immune system (109) . TRIM5α binds to the capsid protein of retroviruses shortly after the virus enters target cells and acts to block reverse transcriptase and/or nuclear entry (110) . Another restriction factor is tetherin (111), a dimeric protein with membrane anchors at its N-and C-terminal ends that tethers newly budded enveloped virions from cells. SAMHD1 seems to block virus replication in certain cell types by reducing the levels of deoxyribonucleoside 5′-triphosphates below those needed by reverse transcriptase (112) . These factors can act to limit the replication of both exogenous and endogenous viruses; their primary function thus remains open to question (54) . Nevertheless, it is clear that they can restrict ERVs that are expressed despite epigenetic controls. Thus, APOBEC3B can act as a brake on LINE amplification (113) and a protective allele of Fv1, a mouse protein functionally related to TRIM5α, can prevent ERV-mediated "spontaneous" leukemia in mice (114) . One attractive idea is that recently acquired ERVs might act to "educate" their hosts, their presence in the germ line driving the evolution of restriction factors with specificity for currently circulating external threats.
An alternative mechanism for host restriction of the virus life cycle is the mutation of host proteins required for viral replication. One common theme is involvement of the cellular receptor for the virus. Mutations affecting virus binding to the receptor without affecting its normal function arise with significant frequency (115) . This provides a convenient means for the host to prevent ERV amplification and provides an explanation for the common phenomenon of "xenotropism," whereby ERVs are unable to reinfect the cells of a host in which they have established a home. For example, MLVs are classified as ecotropic (able to infect mouse), xenotropic (unable to infect mouse), or polytropic (able to infect both mouse and other species), based on the ability of their env glycoproteins to recognize the host-encoded receptor. This phenomenon provides a simple explanation for the frequent isolation of ERVs following the passage of human tumors in immunodeficient animals (6) and suggests a selection pressure for the evolution of ERVs with amplification cycles lacking an extracellular phase.
PATHOGENIC EFFECTS OF ERVs AND RELATED SEQUENCES ON THE HOST Cancer
It is well established that exogenous retroviruses can cause diseases such as AIDS in humans and cancer in animals. The carcinogenic effects of retroviruses are usually the result of either introducing a transduced oncogene or via insertional activation of a host protooncogene by providing ectopic enhancers or promoters (Fig. 3A) (116) . Indeed, retroviruses have been widely used as a tool to detect new oncogenes via mapping of common insertion sites (117) . Replication-competent ERVs closely related to exogenous counterparts, such as MMTV and MLV, can cause malignancy via reinfection and insertional activation of protooncogenes (116) . In AKR mice, specifically selected for a high incidence of cancer, the retroviruses that cause malignancy are the product of recombination between different types of endogenous MLV (118) . Mobilization of IAP ERVs in mice, which have adopted an intracellular life cycle as a retrotransposon (28), can also activate protooncogenes, inducing lymphomas in mice with reduced levels of the maintenance DNA methyltransferase DNMT1 (73) and myeloid leukemia after irradiation in certain inbred strains (119) .
Human ERVs are often transcriptionally upregulated in malignancies, likely due, at least in part, to genomewide DNA hypomethylation (120), but a causative role for such sequences in cancer remains largely speculative (26, 121) . HERV-K (HML-2), the youngest family of ERVs in the human genome, has been extensively investigated for potential pathogenicity and some evidence suggests that the HERV-K-encoded accessory proteins Rec and Np9 have a carcinogenic role, particularly in germ cell tumors, but also in some other cancers (26, 122, 123) . As ongoing retrotranspositional activity of ERVs is low or nonexistent in modern humans (46) , it is not surprising that no instances of activation of oncogenes via new ERV insertions have been found in human malignancy. However, it is possible that existing ERVs or solo LTRs could become transcriptionally active and drive ectopic protooncogene expression, as shown in Fig. 3A . Indeed, this scenario has been reported in Hodgkin lymphoma. In this case, the growth-factor receptor CSF1R is ectopically expressed from a hypomethylated solo LTR of the MaLR THE group specifically in Hodgkin lymphoma cells (124) . Moreover, these cells are dependent on CSF1R for survival (124) . Unlike cases of evolutionary "exaptation" of LTRs where they participate in normal gene regulation (see "ERV/LTR mediated gene regulation" below), this particular THE LTR is transcriptionally silent in normal cells. While intriguing, it remains to be determined how prevalent or significant this phenomenon is with respect to human cancer.
Germ line mutations
As insertional mutagens, ERVs have obvious potential to disrupt genes and cause mutations. In the human, no
ASMscience.org/MicrobiolSpectrum disease-causing mutations have been linked to new ERV insertions, but it is a different story in inbred mice, where at least 10% of all documented germ line mutations with an observable phenotype are due to new ERV insertions (19, 32) . These mutations can be either loss of function via ablation or reduction in normal gene expression, or gain of function by causing ectopic gene expression. Straightforward loss of normal protein expression can occur due to ERV insertions into coding exons. However, exonic insertions are relatively rare, with the vast majority of documented loss-of-function mutations being due to intronic ERV insertions. Such insertions can disrupt normal gene transcript processing by providing splice sites and/or polyadenylation signals, the use of which creates aberrant transcript forms (Fig. 3B ) (for review, see reference 32). Intronic ERVs that significantly disrupt transcript processing are most often oriented in the same transcriptional direction as the enclosing gene, whereas intronic ERVs fixed in a species (and therefore presumably neutral) are heavily biased to be in the opposite or antisense direction, indicating stronger selection against sense-oriented insertions (125, 126, 127) . These findings are expected because the canonical transcript processing signals in a provirus that may be aberrantly recognized during gene transcription typically only operate in sense. One exception is an antisense promoter that exists in IAP LTRs, transcription from which can cause premature gene transcript termination (128, 129) as shown in Fig. 3C . LTRs located downstream of a gene can also promote transcripts antisense to that gene (130) , which could have regulatory effects (Fig. 3C) .
In addition to gene disruption mutations, germ line insertions of IAP elements can cause ectopic gene expression leading to a measurable phenotype with nine such cases reported, four affecting the agouti gene (32, 131, 132) . Most of these cases, including the four impacting agouti, involve the antisense promoter of the IAP 5′ LTR, which drives abnormal gene expression and which shows variable expressivity in genetically identical mice. Such alleles are therefore termed metastable epialleles (133) and are due to the stochastic establishment of variable methylation levels of the LTR. However, studies on the epigenetic inheritance of the LTR epigenetic state, i.e., transgenerational inheritance, suggest that DNA methylation is not the mark that is directly inherited (134).
Auto-immune disorders
As exogenous retroviruses typically elicit an immune response, ERVs have the potential to be involved in autoimmunity and, indeed, have been implicated in the autoimmune disease systemic lupus erythematosus in mice (135) . In addition, in immunodeficient mice lacking antibodies, recombinant and infectious ecotropic MLVs can emerge and induce lymphomas (136) . The lack of functional toll-like receptors, involved in innate immunity (137) , can also lead to the generation of infectious MLV and eventual leukemia (138) . These two studies in mice indicate an important role for the innate and adaptive immune systems in controlling ERVs. As human ERVs are much older than MLV sequences in mice, it might be assumed that the host immune system would have evolved in concert and be unable to recognize human ERV nucleic acids or proteins as foreign. Nonetheless, some human ERV-encoded proteins have been shown to be immunogenic, with antibodies and cytotoxic T cells against ERV proteins being detected in some cancers (139) . Although a true causative role for ERVs in autoimmune diseases is difficult to demonstrate, there is suggestive evidence (140, 141, 142) . For example, the HERV-W-encoded Env protein syncytin1 is upregulated in multiple sclerosis (MS) lesions and its expression in astrocytes induces the production of proinflammatory cytokines and oxidative damage (140) . Such a process leads to oligodendrocyte death, which is a key feature of MS.
ERV PROTEIN DOMESTICATIONS
The widespread distribution and stable genetic inheritance of ERVs has prompted speculation that the provision of "useful" protein functions might provide a partial explanation for their long-term survival. Properties one might expect for ERV gene products playing an essential physiological role would be: (i) conservation of an open reading frame for the protein product in all members of a species or group of species; (ii) a plausible biochemical function: and (iii) expression in the appropriate cell or tissue.
One tissue that has attracted continued interest is the placenta. Placenta formation involves extensive cell fusion to form the syncytial trophoblast layer and it is easy to see how the fusogenic properties of the Env protein might be put to use in this regard. Moreover, the transmembrane (TM) protein of Env contains an immunosuppressive peptide that might also play a role in protecting the developing fetus from maternal immune responses. The first candidate for such a role was the Env protein encoded by the ERV-3 provirus (143). This provirus is conserved in most ape and Old World monkey families and shows specific expression in the placenta. However, sequencing studies revealed that around 1% of the human population have a premature stop codon in the ERV-3 with no evidence for counterselection, thereby indicating that ERV-3 cannot play an essential physiological role (144) . Subsequently, two other Env proteins, encoded by conserved proviruses from the HERV-W (145, 146) and HERV-FRD (147) groups of ERVs, were put forwards as putative placental factors. They are expressed in placental cells and show fusogenic properties. Hence, these ENV proteins were dubbed syncytin-1 and syncytin-2. Based on their species distribution, it seems likely that the proviruses encoding syncytin-1 and -2 have been present in the germ line for approximately 30 million and 45 million years, respectively (147) . The fact that the env genes of these two proviruses have maintained their open reading frames, in contrast to their gag and pol genes, implies selection for the retention of functional proteins. In addition, small interfering RNA-mediated suppression of syncytin expression in spontaneously differentiating trophoblasts interferes with cell-cell fusion, suggesting role(s) in placenta formation (148) .
Direct experimental evidence for the role(s) of ERVencoded proteins in trophoblast formation comes from studies of mice. Although they do not have ERVs at chromosomal locations of syncytin-1 or syncytin-2, genomic sequence analyses of the mouse genome identified two distinct fusogenic env genes with placenta-specific expression, called syncytin-A and -B, that have been conserved for more than 25 million years. Knocking out syncytin-A results in a failure to form organized placentae and midgestational death of homozygotes (149) . Deletion of syncytin-B results in a less dramatic phenotype, although trophoblast fusion is also affected (150) . Apparently, a mechanism involving gap junction formation compensates for fusion loss.
Further examples of ERV capture and utilization in placenta formation have been reported in a variety of mammalian orders, including another rodent species (squirrels), ruminants, carnivores, and lagomorphs (Fig. 4) . All are independent and appear to represent different ERV captures. It is tempting to suggest that the variety of structures of placenta seen in different orders of mammals can be explained by the expression, receptor, and fusion properties of the specific ERVs put to use in each case. This would imply that ERV capture has played a major role in the evolutionary history of placental mammals (151) .
The other area in which ERV gene products have been set to work by the host involves resistance to exogenous infection. The first, and perhaps best-known, example is the murine Fv1 (Friend virus susceptibility-1) gene (152) . This gene shows many functional similarities to the capsidbinding restriction factor TRIM5α, blocking exogenous virus infection at a postentry but preintegration stage in the viral life cycle (110) . It appears to be derived from an ERV related to the MERV-L group, with an open reading frame of about 1.4 kb showing 40% sequence identity to the gag gene of MERV-L (153) . Interestingly, the remaining viral sequences are missing; both promoter and polyadenylation sequences are provided by the host (154) . How Fv1 selects it target and restricts replication are still open questions. Fv1 restriction of infecting viruses involves binding to the retroviral capsid protein (155); however, the detailed mechanisms of target recognition and restriction remain to be elucidated.
A second group of resistance genes correspond to the env gene of certain ERVs. The property of superinfection resistance, whereby cells infected with one retrovirus are resistant to reinfection by a second virus using the same receptor, has been well-described for many years. This phenomenon results from newly synthesized Env binding to a cellular receptor resulting either in downregulation of the receptor on the cell surface or the saturation of virus binding. In either event, fresh virus binding is not possible. Expression of the Env protein from an ERV can mimic this effect, providing protection against infection. This strategy has been used on multiple occasions in a number of different species, including mice, chickens, cats, and sheep, with a variety of ERVs (156, 157, 158) . Under certain circumstances, endogenous Env protein expression may also act to modulate immune responses to infection by acting as a selfantigen (159) . Interestingly, as well as blocking infection of its exogenous counterpart by receptor interference, at least two loci of endogenous Jaagsiekte sheep retrovirus (enJSRV) encode defective Gag proteins that act in a dominant-negative way to block late stages of virus replication (160) .
A different mechanism leading to resistance is associated with expression of the superantigen (sag) gene of endogenous MMTVs. Sag is a type II TM glycoprotein encoded by the MMTV LTR (161) . Expression is needed for exogenous MMTVs to stimulate cell proliferation of target lymphocytes that allow efficient infection as they transfer from gut to mammary gland after infection with a milk-borne virus. When expressed from an ERV and presented with the correct major histocompatibility complex molecule, it can lead to depletion of specific T-cell subsets, sometimes corresponding to 30% of the mature T-cells of the mouse by a mechanism involving stimulation and apoptosis (162) . The absence of target T-cells has the effect of rendering such mice resistant to infection by an exogenous MMTV carrying the same sag gene, but does not appear to compromise immunity to other pathogens (163) .
ERV/LTR MEDIATED GENE REGULATION
Although such protein domestications are remarkable, a wider and more common role for existing ERV sequences is in gene regulation. As discussed above, pathogenic consequences of ERV-mediated gene regulation can occur when they integrate near potential oncogenes and/or ectopically activate such genes via their LTR promoters and/or enhancers (Fig. 3A) . Very similar phenomena can occur in normal cells as an evolutionary adaptation. Notably, although some ERVs retain the general structure of an integrated provirus with retroviral genes and two LTRs, the vast majority of older elements exist currently as solo LTRs due to recombination over time between the 5′ and 3′ LTRs of the provirus (34) . As encoded retroviral LTRs naturally contain promoters and enhancers/transcription factor binding sites, these abundant LTR sequences have inherent potential to regulate genes. A listing of such cases is available (164) and some examples are mentioned here. Among the first well-documented cases of ERVderived genic enhancers are the human amylase loci, where a HERV-E LTR acts as a parotid-specific enhancer (165) , and the sex-limited protein (slp) gene in mouse, which is hormone responsive due to an upstream androgen-response element within an LTR (166, 167) . Another well-studied case occurs in the human betaglobin gene cluster. Strong evidence suggests that an ERV-9 (LTR12) LTR upstream of the locus control region in the cluster recruits transcription factors to downstream globin gene promoters via long range chromatin interactions and expression of a long noncoding (lnc) RNA (168) . Indeed, as discussed further below, ERVmediated involvement in gene regulation via the production of lncRNAs is an intriguing emerging topic.
Although LTR enhancer effects are likely more common due to less positional constraint, it is technically more straightforward to detect LTR promoter exaptations because the LTR sequence forms the 5′ end of the resulting mRNA. By direct screening for LTR-gene chimeric mRNAs or through other methods, numerous individual examples of LTR "promoter donation" in normal cells have been documented (164, 169, 170 , 171, 172). In cases where an LTR acts as a gene promoter, it is most often an alternative promoter with variable contributions to total gene expression and which occasionally creates new or altered tissue specificity of expression (170) . Interesting examples of novel tissuespecific gene expression enabled by an LTR promoter include testis-specific expression of the p63 gene in humans and other primates driven by an ERV-9 LTR (169) and LTR-promoted placental expression of several human genes (for a review, see reference 170). In rarer cases, LTRs can also apparently serve as the primary or sole promoter for a gene, presumably replacing the original or "native" genic promoter due to a favorable integration location and compatible or more advantageous transcription factor binding sites. Examples of such genes include rat Ocm2 (173) and the rodent Naip multigene family, which has adopted an ancient LTR as its primary promoter (174). LTRs have also been shown to provide polyadenylation sites for mRNAs of cellular genes (175) .
In addition to the many examples of ERVs controlling single genes, a growing number of findings implicate ERVs in whole regulatory networks (Fig. 3D ) (for recent reviews, see references 176, 177, 178), supporting the visionary ideas of McClintock (179) and Britten and Davidson (180) , who postulated major roles for transposable elements (TEs) in gene and genome regulation. For example, in 2004 it was reported that Class III mouse ERVs (MT and MERV-L elements) function as alternative promoters for many genes in full-grown oocytes and two-cell embryos, suggesting that such elements may participate in reprogramming of the embryonic genome (78) . The use of computational predictions (181) and genomic approaches such as ChIP-seq (182, 183) has revealed that binding sites for some classes of transcription factors are enriched in ERV LTRs, a finding which is perhaps expected given that LTRs of functioning retroviruses naturally contain transcriptional regulatory modules. One of the first such ChIP-seq studies showed that certain types of human ERV LTRs are enriched in p53 binding sites (183) . Another provocative study showed that binding sites for the pluripotency factors OCT4 and NANOG are largely not conserved between human and mouse ES cells with a large fraction of such nonconserved sites occurring within species-specific ERVs (182) . The presence of such ERV-associated sites is correlated with species-specific gene expression patterns, promoting the suggestion that ERVs have "rewired" the regulatory network in ES cells (182) . A study in mouse has found that RLTR13D5 LTRs are enriched for species-specific enhancer chromatin marks and bind core-transcription factors involved in the regulatory program of trophoblast stem cells (184) . Genome-wide analyses of DNase I hypersensitive sites indicative of open chromatin (185) , as well as patterns of DNA hypomethylation and chromatin marks associated with enhancers (86) , have found significant enrichment in certain classes of human ERVs, suggesting that ERVs are enriched for tissue-specific enhancers.
ERVs can also regulate genes via the production of noncoding RNAs. ERVs and other TEs can promote expression of RNAs antisense to coding genes (Fig. 3C) (130) and a number of more-recent studies indicate that ERV LTRs are overrepresented as a source of transcriptional promoters for lncRNAs (186, 187, 188) . Although many such RNAs could simply be the result of "transcriptional noise" and have no function, regulatory roles for some specific cases are being revealed. As mentioned above, an ERV-9 (LTR12) LTR-promoted lncRNA appears to have a role in the regulation of the beta-globin gene cluster (168) . HERV-H (LTR7)-promoted transcripts/lncRNAs are particularly abundant in undifferentiated human ES cells (187, 189) , correlating with their association with DNAse I hypersensitive sites, hypomethylation, active chromatin marks, and the binding of pluripotency transcription factors (182, 185, 189, 190) . Indeed, there is growing evidence that HERV-H-derived RNAs play an important, regulatory role in human stem cell identity and maintenance of pluripotency (191, 192, 193, 194) . In mouse, the nonautonomous VL30 ERVs have been shown to produce enhancer-associated noncoding RNAs controlled by Trim24 and involved in gene regulation in hepatocytes (195) . As the field of noncoding RNA continues to grow, it is likely that many cellular roles for ERV-derived RNAs will be uncovered.
CONCLUDING REMARKS
ERVs and ERV remnants are vestiges of the continual bombardment of their host genome by exogenous retroviruses during evolution. It is worth emphasizing that the ERVs in present-day mammalian genomes [e.g., ∼400,000 loci in humans (18)] represent only a tiny fraction of the retroviral insertions that have occurred in the germ line, have survived natural selection, and have gone to fixation. Therefore, it is interesting to contemplate the level of activity by retroviruses and other viruses (and their associated diseases) that must have shaped the population history of a species and driven the rapid evolution of host genes to counter new viral threats (196) . Although the activity of ERVs appears to have died out in some species, notably human, several ERV groups are active in mouse, the organism most widely used to model human disease. Here we have reviewed the discovery of ERVs in mammals, mechanisms that curtail their expression, and their biological effects. ERVs have an enigmatic relationship with their host species. On the one hand, the negative effects of active ERVs as genomic mutagens and cancer-causing agents are well established. On the other hand, examples of ERV-protein domestications to serve host functions, as in placental development, are also clear. Moreover, there is growing evidence that the gene regulatory potential of ERV LTRs has been exploited multiple times during evolution to regulate genes and gene networks. Thus, although recently endogenized retroviral elements are often pathogenic, those that survive the forces of negative selection or loss by genetic drift become neutral components of the host genome or can be harnessed to serve beneficial roles.
